Colgate-Palmolive Company Files Form 8-K: Key Details for Investors

Colgate-Palmolive Company (NYSE: CL) has filed a Form 8-K with the U.S. Securities and Exchange Commission, dated March 12, 2026. Below is a detailed breakdown of the filing, with particular attention to information that may be relevant for shareholders and could potentially be price-sensitive.

1. Key Points from the Form 8-K Filing

• Type of Filing: Form 8-K, a current report filing used to announce major events that shareholders should know about.
• Filing Date: March 12, 2026
• Company Information:
  • Registrant: Colgate-Palmolive Company
  • Business Address: 300 Park Avenue, New York, NY 10022
  • Phone Number: (212) 310-2000
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 1-644
  • Tax Identification Number: 13-1815595
• Security Listings: The filing lists several securities registered under Section 12(b) of the Exchange Act, each with its trading symbol and the exchange where it is listed:
  • Common Stock, \$1.00 par value (Trading Symbol: CL) – New York Stock Exchange (NYSE)
  • 0.300% Notes due 2029 (Trading Symbol: CL29) – NYSE
  • 1.375% Notes due 2034 (Trading Symbol: CL34) – NYSE
  • 3.250% Notes due 2035 (Trading Symbol: CL35) – NYSE
  • 0.875% Notes due 2039 (Trading Symbol: CL39) – NYSE
• Emerging Growth Company Status: Colgate-Palmolive is not an emerging growth company under SEC definitions.
• Amendment Flag: The filing is not an amendment to a previously filed document.
• Other SEC Communications: The filing is not related to written communications under Rule 425, soliciting material under Rule 14a-12, or pre-commencement tender offer communications under Rule 14d-2(b) or 13e-4(c).
• Signatory: The report is signed by Jennifer M. Daniels, on behalf of Colgate-Palmolive Company as of March 12, 2026.

2. Price-Sensitive Information and Shareholder Impact

• No Price-Sensitive Event Disclosed: The Form 8-K does not disclose any material event such as mergers, acquisitions, changes in control, changes in executive leadership, financial restatements, or other actions that would typically be considered price-sensitive or likely to materially impact Colgate-Palmolive’s share price.
• Routine Filing: The filing appears to be a routine update regarding the company’s registered securities and compliance status, with no new business developments or strategic transactions announced.

3. What Investors Should Know

• Current Status of Securities: Investors are reminded of the company’s current mix of common stock and long-term notes, all actively traded on the NYSE under the symbols CL, CL29, CL34, CL35, and CL39.
• No Impending Corporate Actions: There are no signals in this filing of upcoming corporate actions (such as buybacks, M&A, or changes to dividend policy) that would affect shareholder value.
• Ongoing Compliance: The company remains in good standing with the SEC, with all required disclosures and no indication of compliance issues.

Conclusion

After a detailed review, this Form 8-K from Colgate-Palmolive Company is informational and does not contain any newsworthy or price-moving disclosures. Unless further filings or press releases are issued with substantive updates, shareholders and investors are unlikely to see any impact on CL’s share price based on this report.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence or consult with a financial advisor before making investment decisions. The author and publisher are not responsible for investment actions taken based on this report.

View COLGATE PALMOLIVE CO Historical chart here